Linganisha mbinu

	TED-QoL / GO-QoL: Dodoso la Ubora wa Maisha kwa Ugonjwa wa Jicho la Tezi Dume	Orodha ya Dalili za Hyperthyroidism
Nyanja	Endokrinolojia	Endokrinolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2001	1997
Mwanzilishi	Caroline Terwee, Markus Gerding, Frank Dekker	Multiple authors; consensus from Endocrine Society
Aina	Patient self-report questionnaire	Patient self-report symptom checklist
Chanzo asilia	Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779.	Engel, G. L., Dayan, A. D., Thorn, G. W., et al. (1997). Hyperthyroidism: A multisystem disease with diverse manifestations. Adv Intern Med, 42, 55-91.
Majina mbadala	GO-QoL, Graves Ophthalmopathy Quality of Life	HSC, Hyperthyroid Symptom Inventory
Zinazohusiana	3	3
Muhtasari	The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment.	The Hyperthyroidism Symptom Checklist is a structured assessment tool for quantifying the symptom burden of Graves' disease and other thyrotoxicosis conditions. It captures the multisystem manifestations of excess thyroid hormone: cardiovascular (palpitations, tachycardia, arrhythmia), neuropsychiatric (anxiety, tremor, insomnia), metabolic (heat intolerance, weight loss, appetite), and eye-specific symptoms (in Graves' ophthalmopathy). Used in endocrinology practice and clinical trials to monitor disease activity and treatment response.